ACTIVATED
COMPLEMENT
IN
THE
SPUTUM
FROM
PATIENTS
WITH
CYSTIC
FIBROSIS
14
CYSTIC
FIBROSIS
CF
PATIENTS
CHRONICALLY
INFECTED
WITH
MUCOID
P
AERUGINOSA
AND
PRESENTING
MULTIPLE
PRECIPITINS
IN
SERUM
AGAINST
THIS
BACTERIUM
CF

P
AND
13
CF
PATIENTS
WITHOUT
P
AERUGINOSA
INFECTION
CFP
HAD
THEIR
PLASMA
AND
SPUTUM
SOL
PHASE
EXAMINED
FOR
ALBUMIN
CLQ
C3C3C
C4
AND
C5
BY
MEANS
OF
ELECTROIMMUNOASSAYS
THEIR
SPUTUM
SOL
PHASE
WAS
EXAMINED
ALSO
FOR
FACTOR
B
BY
ROCKETIMMUNOELECTROPHORESIS
C3C
WAS
DEMONSTRATED
IN
THE
SPUTUM
SOL
PHASE
BUT
SIGNIFICANTLY
MORE
FREQUENT
P
LESS
THAN
001
AMONG
THE
CF

P
PATIENTS
THAN
AMONG
THE
CFP
PATIENTS
FACTOR
B
WAS
ALSO
DEMONSTRATED
IN
THE
SPUTUM
SOL
PHASE
BUT
NO
SIGNIFICANT
DIFFERENCE
IN
FREQUENCY
COULD
BE
DEMONSTRATED
BETWEEN
THE
CF

P
AND
THE
CFP
PATIENTS
NONE
OF
THE
RESULTS
INDICATED
THAT
A
LOCAL
PULMONARY
PRODUCTION
OF
COMPLEMENT
FACTORS
TOOK
PLACE
COMPLEMENT
ACTIVATION
WAS
SIGNIFICANTLY
P
LESS
THAN
001
ASSOCIATED
WITH
INFLAMMATION
EXPRESSED
AS
INCREASED
FORMULA
SEE
TEXT
THE
RESULTS
SHOW
THE
IMPORTANCE
OF
COMPLEMENT
MEDIATED
INFLAMMATION
IN
THE
PATHOGENESIS
OF
PULMONARY
TISSUE
DAMAGE
IN
PATIENTS
WITH
CF
AND
SUPPORT
THE
CONCEPT
OF
CHRONIC
P
AERUGINOSA
LUNG
INFECTION
AS
AN
IMMUNE
COMPLEX
DISEASE
IN
CF
PATIENTS
